Susceptibility Of Copd And Cigarette Smoke Airway Epithelia To Sars-Cov-2
- Funded by Animal Free Research UK
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Funder
Animal Free Research UKPrincipal Investigator
Dr. Baishakhi GhoshResearch Location
United KingdomLead Research Institution
Johns Hopkins HospitalResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The lungs are the organs most affected by COVID-19 as the SARS-CoV-2 virus results in asymptomatic or mild symptoms hospitalizations and mortality due to respiratory failure. Given the enormous impact of the virus on health and well-being, it is important to get insight into its pathogenic interaction with humans. We are exploring the epithelial changes that lead to increased susceptibility to disease, and also, quantifying changes that occur after viral exposure to determine the likelihood of chronic respiratory disease even after recovery from acute infection. Our understanding of the role of environmental exposures such as cigarette-smoke or vaping electronic cigarettes in modifying the response to SARS-CoV-2 is emerging and smoking has been associated with worsened outcomes in SARS-CoV-2 patients. The proposed study will improve our understanding of how cigarette smoke increases our susceptibility to SARS-CoV-2 infection in the lungs and help in developing a therapy for prevention and treatment.